US · Healthcare

Madrigal Pharmaceuticals Inc (MDGL)

Biotechnology

Madrigal Pharmaceuticals Inc (MDGL) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MDGL

P/E ratio

18.00

Madrigal Pharmaceuticals Inc (MDGL) — FAQ

What is MDGL's P/E ratio?

The price-to-earnings (P/E) ratio for Madrigal Pharmaceuticals Inc (MDGL) is 18.00 (data as of 2026-03-24).

Does Madrigal Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Madrigal Pharmaceuticals Inc (MDGL). Check the MyAverix Finance app for the latest dividend data.

What sector is Madrigal Pharmaceuticals Inc in?

Madrigal Pharmaceuticals Inc (MDGL) is classified in the Healthcare sector (Biotechnology industry).

What exchange is MDGL listed on?

MDGL is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)